|
[Related PubMed/MEDLINE]
Total Number of Papers: 8
|
|
|
|
|
[Display Entries]
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: AATs |
| Long Form |
: antiangiogenic therapies |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways. |
GBM, TKIs, VEGF, VEGFRs |
| 2 |
2020 |
MiR-9 Promotes Angiogenesis via Targeting on Sphingosine-1- Phosphate Receptor 1. |
miR, S1P |
| 3 |
2019 |
Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. |
HUVECs, miR, VEGF |
| 4 |
2018 |
CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma. |
GBM, IL-8, VM |
| 5 |
2018 |
Sexual Disorders of Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Antiangiogenic Therapies. |
CSFQ, FACT-G, mRCC, QOL |
| 6 |
2017 |
Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling. |
--- |
| 7 |
2016 |
Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma. |
GBM |
| 8 |
2016 |
Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer. |
mRCC, QOL |
|
A Search Service for Abbreviation / Long Form
